MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11136-011-0027-0

Медицинская библиотека · Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2011

Health-related quality of life changes associated with buprenorphine treatment for opioid dependence.

Raisch Dennis W, Campbell Heather M, Garnand David A, Jones Mark A, Sather Mike R, Naik Rupali, Ling Walter

СтатьяПоддержка NIH: внешняя программаПоддержка правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Few studies have described improvement in health-related quality of life (HRQOL) associated with opioid dependence treatment with buprenorphine (ODT-B).

OBJECTIVE

To evaluate HRQOL changes in domain scores, physical and mental component summaries, and health utilities (HUs) associated with ODT-B using the Short Form 36 (SF-36).

METHODS

We assessed HRQOL changes in a substudy of a pharmacokinetic study that compared buprenorphine oral tablet and liquid dosage formulations over 16 weeks. Individuals, aged 18-65 years, were screened for opioid dependence. They were excluded if they would not agree to birth control or had a serious medical condition. Subjects received psychosocial counseling and weekly group therapy. The SF-36 was administered upon enrollment and at 4-week intervals. We used the SF-6D to estimate HUs. We performed intention to treat (ITT) analyses based on the last observation available for each subject. Paired t tests of each domain and HU, limited to remaining patients at each 4-week interval, were also conducted.

RESULTS

Of 96 subjects enrolled, cumulative dropouts over time resulted in 80, 69, 59, and 44 subjects remaining at 4, 8, 12, and 16 weeks. There were no significant differences in opioid-positive urines, dropout rates, or dosage changes between formulations. In the ITT analyses, HRQOL improvements over time were bodily pain (62.1 vs. 69.1, P = 0.017), vitality (49.8 vs. 56.5, P = 0.001), mental health (59.9 vs. 66.0, P = 0.001), social function (66.4 vs. 74.7, P = 0.001), role emotional (59.4 vs. 71.9, P = 0.003), role physical (60.9 vs. 70.6, P = 0.005), and mental component summary (41.9 vs. 45.4, P<0.001). HU scores also improved (0.674 vs. 0.715, P = 0.001). Results from paired t tests, with only concurrently enrolled patients, showed similar improvements from baseline to 4, 8, 12, or 16 weeks.

CONCLUSION

Buprenorphine, accompanied with psychosocial counseling, was associated with improved HRQOL and HUs.

Для цитирования: Raisch Dennis W, Campbell Heather M, Garnand David A, Jones Mark A, Sather Mike R, Naik Rupali, Ling Walter. Health-related quality of life changes associated with buprenorphine treatment for opioid dependence.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2011. DOI: 10.1007/s11136-011-0027-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.